Publicaciones en colaboración con investigadores/as de Universitat Pompeu Fabra (23)

2023

  1. Apoptotic cell death in disease—Current understanding of the NCCD 2023

    Cell Death and Differentiation, Vol. 30, Núm. 5, pp. 1097-1154

2021

  1. A proteomic approach for systematic mapping of substrates of human deubiquitinating enzymes

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome

    Neurobiology of Disease, Vol. 127, pp. 210-222

  2. Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Absence of Tangentially Migrating Glutamatergic Neurons in the Developing Avian Brain

    Cell Reports, Vol. 22, Núm. 1, pp. 96-109

  2. Role of the endocannabinoid system in drug addiction

    Biochemical Pharmacology, Vol. 157, pp. 108-121

2017

  1. CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal

    Biological Psychiatry, Vol. 81, Núm. 7, pp. 625-634

2016

  1. Differential control of cocaine self-administration by GABAergic and glutamatergic CB1 cannabinoid receptors

    Neuropsychopharmacology, Vol. 41, Núm. 9, pp. 2192-2205

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Possible therapeutic doses of cannabinoid type 1 receptor antagonist reverses key alterations in fragile X syndrome mouse model

    Genes, Vol. 7, Núm. 9

  4. Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome

    Molecular Brain, Vol. 9, Núm. 1

2013

  1. A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior

    Neuropsychopharmacology, Vol. 38, Núm. 9, pp. 1724-1736

  2. An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure

    Neuroscience Letters, Vol. 557, Núm. PB, pp. 101-106

  3. Targeting the endocannabinoid system in the treatment of fragile X syndrome

    Nature Medicine, Vol. 19, Núm. 5, pp. 603-607

2012

  1. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal

    Biological Psychiatry, Vol. 71, Núm. 3, pp. 214-223

  2. Influence of δ-opioid receptors in the behavioral effects of nicotine

    Neuropsychopharmacology, Vol. 37, Núm. 10, pp. 2332-2344

  3. The hypocretin/orexin system: Implications for drug reward and relapse

    Molecular Neurobiology, Vol. 45, Núm. 3, pp. 424-439

2011

  1. Deletion of the δ opioid receptor gene impairs place conditioning but preserves morphine reinforcement

    Biological Psychiatry, Vol. 69, Núm. 7, pp. 700-703

2010

  1. Effects of repeated MDMA administration on the motivation for palatable food and extinction of operant responding in mice

    Psychopharmacology, Vol. 208, Núm. 4, pp. 563-573